Additional information | |
|---|---|
| Department | SPECIAL TESTS |
| Speciality Name | p ANCA QUANTITATIVE* |
| Test type | Pathology |
| Report | |
| Availability | All centre |
No Patient preparation needed
The P-ANCA Quantitative Test is a specialized laboratory blood test that measures the level of Perinuclear Anti-Neutrophil Cytoplasmic Antibodies (P-ANCA) in the circulation. These autoantibodies are formed when the immune system mistakenly assaults its own neutrophils, which are white blood cells that protect the body from infections. P-ANCA antibodies are linked to a variety of autoimmune diseases, including ANCA-associated vasculitis, a kind of inflammation that affects small and medium-sized blood vessels. Measuring the precise amount of P-ANCA antibodies gives useful information to healthcare providers in diagnosing autoimmune disorders, assessing disease activity, monitoring therapy response, and assessing the risk of disease progression. Unlike qualitative tests, which merely indicate if antibodies are present or absent, quantitative tests establish their concentration, making them valuable for both diagnosis and long-term follow-up.
A P-ANCA Quantitative Test assesses the presence of perinuclear anti-neutrophil cytoplasmic antibodies in blood samples. These antibodies are typically directed against an enzyme called myeloperoxidase (MPO), which is present in neutrophils. In autoimmune illnesses, the immune system develops antibodies against MPO and other neutrophil components, causing blood vessel inflammation and organ damage. The test is typically carried out using modern immunological techniques such as Enzyme-Linked Immunosorbent Assay (ELISA), which offers an exact numerical value for antibody concentration. This quantitative measurement allows clinicians to detect whether antibody levels are rising, falling, or maintaining stable following treatment.
Doctors recommend the P-ANCA Quantitative Test when they suspect an autoimmune disease involving blood vessel inflammation or certain inflammatory disorders affecting several organs. The test is frequently used to explore chronic symptoms that cannot be explained by normal laboratory tests. It is especially effective in the diagnosis of Microscopic Polyangiitis (MPA), Eosinophilic Granulomatosis with Polyangiitis (EGPA) (formerly Churg-Strauss disease), and certain types of rapidly progressing glomerulonephritis. The test may also be advised for individuals with chronic renal inflammation, unexplained lung disease, recurrent sinus difficulties, inflammatory bowel disease, autoimmune liver disorders, or persistent constitutional symptoms like fever, exhaustion, and weight loss. Physicians frequently use the test to track disease activity in patients with ANCA-associated vasculitis and to assess the efficacy of immunosuppressive medication.
Elevated P-ANCA levels are most often related with autoimmune vasculitis, although they can also occur in a variety of other inflammatory diseases. Microscopic Polyangiitis (MPA), Eosinophilic Granulomatosis with Polyangiitis (EGPA), pauci-immune crescentic glomerulonephritis, autoimmune hepatitis, primary sclerosing cholangitis, ulcerative colitis, and, less commonly, Crohn's disease are all associated with antibodies. Positive P-ANCA findings can also be seen in rheumatoid arthritis, systemic lupus erythematosus, and other autoimmune diseases. P-ANCA antibodies can occasionally be identified in disorders other than vasculitis, therefore test results should always be interpreted in conjunction with clinical symptoms, imaging studies, and other laboratory investigations.
If a patient develops signs of autoimmune vasculitis or unexplained systemic inflammation, their healthcare provider may recommend the P-ANCA Quantitative Test. Symptoms may include persistent fever, unexplained fatigue, weight loss, persistent joint pain, muscle weakness, skin rashes, numbness or tingling in the hands and feet, blood in the urine, leg swelling, chronic sinusitis, nasal congestion, recurrent nosebleeds, coughing, shortness of breath, coughing up blood, chest discomfort, abdominal pain, chronic diarrhea, and unexplained kidney dysfunction. Because these symptoms can affect several organ systems, laboratory testing is essential in determining the underlying autoimmune disease.
The P-ANCA Quantitative Test is often used to diagnose autoimmune vasculitis or inflammatory illnesses affecting the kidneys, lungs, liver, intestines, or blood vessels. Patients with unexplained renal illness, prolonged respiratory symptoms, inflammatory bowel disease, autoimmune liver disease, or unexpected urine results may benefit from this study. Individuals with a family history of autoimmune diseases, patients with recurring episodes of vasculitis, and those who require continuing monitoring following therapy for ANCA-associated disorders can all benefit from the test.
The patient is instructed to sit comfortably during blood collection.
The P-ANCA Quantitative Test findings are typically presented numerically, along with the laboratory's reference range. A normal or negative result often suggests that P-ANCA antibodies are undetectable or present at extremely low levels. An increased P-ANCA level indicates autoimmune activity and may aid in the diagnosis of ANCA-associated vasculitis or another autoimmune disease. However, a positive test does not necessarily indicate the presence of a specific disease. Doctors interpret the data in light of the patient's symptoms, physical examination, imaging studies, renal function tests, inflammatory markers, and, in some situations, tissue biopsies. Repeat testing may also be used to track changes in antibody levels during treatment.
Although the P-ANCA Quantitative Test is quite useful, it does have certain limitations. Elevated antibody levels do not always indicate active illness, and some patients with autoimmune vasculitis may show negative P-ANCA readings. False-positive results can arise in inflammatory bowel illness, autoimmune liver disease, and certain infections. As a result, the test should never be used to make a diagnosis on its own. Clinical examination, imaging studies, kidney function testing, and, if necessary, tissue biopsy remain critical for confirming the diagnosis and assessing the extent of organ damage.
The P-ANCA Quantitative Test requires simply a regular blood sample and is regarded quite safe. Minor adverse effects may include transient pain at the needle insertion site, bruising, moderate bleeding, disorientation, and, in rare cases, infection. These effects are typically minor and resolve without issues.
The P-ANCA Quantitative Test is a critical laboratory study for detecting and monitoring autoimmune disorders characterized by blood vessel inflammation. The test gives useful information on disease activity, therapy response, and the possibility of autoimmune vasculitis by precisely quantifying the concentration of perinuclear anti-neutrophil cytoplasmic antibodies. It is especially beneficial in the diagnosis of Microscopic Polyangiitis (MPA), Eosinophilic Granulomatosis with Polyangiitis (EGPA), autoimmune kidney illnesses, inflammatory bowel disease, and several autoimmune liver diseases. Although the test is extremely useful, its results should always be interpreted in conjunction with clinical findings, imaging tests, and additional laboratory investigations. Early diagnosis and therapy based on a full evaluation can help prevent irreparable organ damage and improve the quality of life for people suffering from autoimmune illnesses.
The P-ANCA Quantitative Test detects the presence of Perinuclear Anti-Neutrophil Cytoplasmic Antibodies (P-ANCA) in the bloodstream. It is largely used to identify and track autoimmune illnesses like Microscopic Polyangiitis (MPA), Eosinophilic Granulomatosis with Polyangiitis (EGPA), and other ANCA-related vasculitis. The test also helps to diagnose autoimmune kidney, liver, and inflammatory bowel illnesses.
No, fasting is typically not required prior to a P-ANCA Quantitative test. You may eat and drink normally unless your doctor has prescribed extra blood tests that necessitate fasting. Before the test, tell your doctor about any medications you're taking, especially immunosuppressive drugs or corticosteroids.
A P-ANCA Quantitative test in Delhi normally costs between ₹1,500 and ₹3,500, depending on the diagnostic center, laboratory equipment, and testing methodology. Prices can vary between laboratories, therefore it is best to clarify the most recent prices with your favorite diagnostic centre before scheduling the test.
A positive P-ANCA. A quantitative test detects high amounts of P-ANCA antibodies in the blood. This could indicate the existence of an autoimmune condition such as Microscopic Polyangiitis (MPA), Eosinophilic Granulomatosis with Polyangiitis (EGPA), or another inflammatory disorder. However, the test cannot confirm a diagnosis; therefore, your doctor may request other investigations, such as MPO antibody testing, imaging examinations, or a biopsy, to discover the specific cause.
P-ANCA Quantitative tests are available near you at NABL-accredited pathology laboratories, rheumatology clinics, nephrology centers, and advanced diagnostic laboratories. Choosing a reputed diagnostic center with skilled laboratory workers and sophisticated immunology testing facilities improves the accuracy, reliability, and timeliness of test findings.
Related tests